GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Equasens EQS.PA · EUR

Health Care · Euronext Paris · 🇫🇷 France

Compare

27.75

-0.18%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Equasens

Its shares trade on Euronext Paris under the ticker EQS.PA. It has been listed since 20 October 2000. In the fiscal year to 31 December 2025, it reported revenue of €236.5m and net income of €39.3m. At that date it held total assets of €439.0m and shareholders' equity of €252.3m.

Pharmagest Interactive SA engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. The company operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
20 Oct 2000
Employees
757

Leadership

Pay as last reported

  • Mr. Thierry ChapusotChairman of the Board, since 2010€717,424
  • Mr. Denis SupplissonChief Executive Officer, Member of the Management Board, Director€227,237
  • Mr. Gregoire de RotalierDeputy Chief Executive Officer, Director, since 2020
  • Ms. Frederique SchmidtFinance Director, Director, since 2023
  • Mr. Daniel AntoineDirector€7,062
  • Mr. Jean-pierre DosdatDirector
  • Mr. Francois JacquelDirector€7,770
  • Ms. Emilie LecomteDirector€604
  • Mrs. Anne LhoteDirector€1,068
  • Mr. Dominique PautratDirector, since 2000€24,000
  • Mrs. Celine GrisIndependent Director€6,177
  • Mrs. Sophie MayeuxIndependent Director€6,531

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Pharmagest Interactive SA has several strengths that contribute to its success:

Weaknesses

  • However, Pharmagest Interactive SA also faces some weaknesses that it needs to address:

Opportunities

  • There are several opportunities that Pharmagest Interactive SA can capitalize on:

Threats

  • Pharmagest Interactive SA should also be aware of the following threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.